Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 14, 2018

Primary Completion Date

January 11, 2019

Study Completion Date

January 11, 2019

Conditions

Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease

Interventions

DRUG

[18F]FSPG

Patients will receive 200 MBq of \[18F\]FSPG and undergo PET/CT for assessing disease activity in inflammatory bowel disease

Trial Locations (2)

Asan Foundation, Seoul